VeraDermics
MANE----
VeraDermics (MANE)
Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The c...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
VeraDermics Analyst Rating
View MoreForecast & Rating
Jul 21, 2026Price forecast
$163.5049.30%
Forecast & RatingStrong buy
7analysts
- Strong buy85.71%
- Buy14.29%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 1 hour ago
Fragmented Trading in US Niche Stocks Driven by AI and Diagnostic Catalysts
- Tip Ranks · Jul 18 at 04:05 PM
Veradermics, Incorporated (MANE) Receives a Buy from LifeSci Capital
- rttnews · Jul 18 at 12:22 AM
Weekly Buzz: NVS, MRK Win FDA Nod; LLY Snaps Up ATAI; MANE Shines On Hair Loss Data
- Price Alert · Jul 17 at 12:38 PM
U.S. stock market midday update: VeraDermics up 8.39%, oral hair loss medication clinical benefits boost stock price
- PUBT · Jul 17 at 06:30 AM
Veradermics to present age-subgroup data from VDPHL01 male hair loss trial at AAD Innovation Academy
- StockTitan · Jul 16 at 10:30 PM
Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302’ in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy | MANE Stock News
